AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Recce Pharmaceuticals Ltd
Video analysis: RCE.AX
All videosNo video analysis for this stock yet. Request one from our team.
News: RCE.AX
Snowflake shares surge after Q2 beat, raised guidance
Snowflake Inc (NYSE:SNOW) shares jumped 23% in after-hours trading Wednesday after the cloud data company posted second-quarter results that beat Wall...
Polymarket valuation hits $21bn as Trump Jr's firm leads $1bn round
Polymarket, the blockchain-based prediction-market platform, is raising $1 billion in a new funding round that values the company at $21 billion on a...
Baidu misses Q2 revenue and earnings estimates as core business slips
Baidu.com (NASDAQ:BIDU) shares fell 9.3% in Tuesday morning trading after the Chinese tech giant reported second-quarter results that missed analyst...
Bank of England holds rates but three dissenters vote for hike
The Bank of England held interest rates at 3.75% but three policymakers voted for an increase as renewed tensions in the Middle East raised the risk of...
Recce Pharmaceuticals positioned for US$66.9 billion US biodefence strategy
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is positioned to benefit from a new five-year, US$66.9 billion US Government strategy aimed at strengthening...
Recce Pharmaceuticals advances dual Phase 3 programs and MENA licensing strategy in strong June quarter
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) advanced its diabetic foot infection treatment toward commercialisation during the June quarter, securing...
Twilio faces higher bar heading into quarterly earnings, says Jefferies
Twilio Inc (NYSE:TWLO) is expected to deliver second quarter results that exceed expectations on revenue and operating income, with investors likely to...
Halliburton tops Q2 earnings estimates as CEO warns of softer oilfield services market
Halliburton Company (NYSE:HAL, XETRA:HAL) reported second quarter results that exceeded Wall Street expectations, but shares fell more than 6% after...
Similar companies
-
Actinogen Medical Limited
ACW.AX
·
Australian Securities Exchange
Compare
-
Arovella Therapeutics Limited
ALA.AX
·
Australian Securities Exchange
Compare
-
Alterity Therapeutics Limited
ATH.AX
·
Australian Securities Exchange
Compare
-
Imugene Limited
IMU.AX
·
Australian Securities Exchange
Compare
-
Island Pharmaceuticals Limited
ILA.AX
·
Australian Securities Exchange
Compare
-
EZZ Life Science Holdings Limited
EZZ.AX
·
Australian Securities Exchange
Compare